Financial Summary (All financials)
In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
Revenues | 3,798.5 | 3,775.7 | 3,588.1 | 3,280.3 | 1,620.3 | 1,281.7 | 1,151.2 | 1,079.1 |
Revenue growth | 0.6% | 5.2% | 9.4% | 102.5% | 26.4% | 11.3% | 6.7% | 5.4% |
Cost of goods sold | 1,372.3 | 1,357.0 | 1,188.2 | 1,173.1 | 592.7 | 467.1 | 432.2 | 419.2 |
Gross profit | 2,426.2 | 2,418.7 | 2,399.9 | 2,107.3 | 1,027.6 | 814.6 | 719.0 | 659.9 |
Gross margin | 63.9% | 64.1% | 66.9% | 64.2% | 63.4% | 63.6% | 62.5% | 61.2% |
Selling, general and administrative | 1,054.6 | 1,009.0 | 1,023.2 | 987.1 | 499.3 | 416.1 | | |
Sales and marketing | | | | | | | 232.4 | 204.0 |
Research and development | 341.9 | 377.9 | 375.5 | 337.1 | 142.5 | 115.8 | 104.3 | 97.8 |
General and administrative | | | | | | | 150.1 | 117.8 |
EBITA | 1,042.3 | 1,037.0 | 1,007.1 | 796.5 | 385.8 | 282.7 | 242.1 | 248.9 |
EBITA margin | 27.4% | 27.5% | 28.1% | 24.3% | 23.8% | 22.1% | 21.0% | 23.1% |
Amortization of intangibles | 302.9 | 313.9 | 299.6 | 296.0 | 86.9 | 98.7 | 120.6 | 118.9 |
EBIT | 739.4 | 723.1 | 707.5 | 500.5 | 298.9 | 184.0 | 121.5 | 130.0 |
EBIT margin | 19.5% | 19.2% | 19.7% | 15.3% | 18.4% | 14.4% | 10.6% | 12.0% |
Pre-tax income | 531.8 | 478.7 | 441.6 | 194.5 | 112.2 | 139.2 | 104.1 | 159.5 |
Income taxes | 101.4 | 100.9 | 63.7 | 50.0 | 107.9 | 33.0 | 28.3 | 38.1 |
Tax rate | 19.1% | 21.1% | 14.4% | 25.7% | 96.1% | 23.7% | 27.2% | 23.9% |
Earnings from continuing ops | 430.9 | 378.5 | 378.3 | 144.6 | 4.4 | 106.2 | 75.8 | 121.5 |
Earnings from discontinued ops | | | | | 1.4 | 12.9 | -266.8 | 10.6 |
Net income | 430.9 | 378.5 | 378.3 | 144.6 | 5.7 | 119.1 | -191.0 | 132.0 |
Net margin | 11.3% | 10.0% | 10.5% | 4.4% | 0.4% | 9.3% | -16.6% | 12.2% |
|
Diluted EPS | $2.40 | $2.04 | $1.98 | $0.80 | $0.04 | $1.09 | $716.57 | $2.02 |
Shares outstanding (diluted) | 179.4 | 185.6 | 190.6 | 181.4 | 103.7 | 97.1 | 0.1 | 60.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|